About this trial
Granulomatous mastitis (GM) is a non-infectious inflammatory breast condition typically affecting young women, often following breastfeeding. Management of GM often begins with anti-inflammatory medications and antibiotics. Steroids, particularly intralesional corticosteroids, are considered the first-line treatment for GM due to their rapid anti-inflammatory and immunosuppressive effects. Steroids help control symptoms such as painful lumps, swelling, and redness. Steroids' effectiveness in providing symptom relief minimizes the need for more invasive treatments such as surgery.
Eligibility criteria
Qualifiers
Women diagnosed with IGM confirmed clinically and histopathologically , willing to undergo intralesional steroid treatment.
Disqualifiers
Patients with active infections.
Patients on immunosuppressive therapy.
pregnant women.
Trial design
Treatments tested in this trial
- Ultrasound guided intralesional Steroids injection (Triamicinolone)